Analysis of how liver-specific transcriptional regulation factors are implicated in hepatocytic differentiation and oncogenesis ; their application for histo- and clinicopathological diagnosis
分析肝脏特异性转录调控因子如何参与肝细胞分化和肿瘤发生;
基本信息
- 批准号:07457050
- 负责人:
- 金额:$ 5.06万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Hepatic nuclear factor 1 (HNF-1), as a transcription regulator, binds the promoters or enhancers of genes expressed almost exclusively in liver. We have previously reported that the ratio of HNF-1alpha and HNF-1beta mRNA is related to histological differentiation of hepatocellular carcinoma (HCC) (Ninomiya T et al., J Hepatol, 25 : 445-453,1996). Furthermore, to investigate the expression pattern in HCCs, we relatively quantitatively compared the expression of HNF-1alpha and HNF-1beta proteins in various histologically differentiated cancerous as well as surrounding noncancerous tissues and their binding activity for B element in alpha-fetoprotein enhaner. The polyclonal antibodies for human HNF-1alpha and HNF-1beta were generated by Glutathione S-transferase fussion protein. Nuclear extracts were prepared from the tested tissues. The expression of HNF-1alpha and HNF-1beta proteins in isolated nuclei were measured by western blotting and their binding activity examined by gel mobility assay. Immunohistochemistry were performed in frozen and parafin embedded sections. Western blottings demonstrated that HNF-1alpha protein was overexpressed in well differentiated HCC tissues but decreased from well differentiated to poorly differentiated HCCs compared with surrounding non-HCC tissues. The HNF-1beta expression did not after from well differentiated to poorly differentiated HCCs athough it is more abundant in cancerous tissues than the surrounding noncancerous portions. In gel mobility assay, the decreasing tendency was shown in the assay of HNF-1alpha binding activity. These findings provide an evidence involved in effect of HNF-1alpha alteration on the differentiations of HCC that the histological differentiation of HCC turns poor when HNF-1alpha expression decreases and HNF-1beta competes to bind the elements formerly occupied by HNF-1alpha (Wang W et al., J Pathol in press).
肝核因子 1 (HNF-1) 作为转录调节因子,与几乎只在肝脏中表达的基因的启动子或增强子结合。我们先前报道过HNF-1α和HNF-1βmRNA的比率与肝细胞癌(HCC)的组织学分化有关(Ninomiya T等人,J Hepatol,25:445-453,1996)。此外,为了研究HCC中的表达模式,我们相对定量地比较了各种组织学分化的癌组织以及周围非癌组织中HNF-1α和HNF-1β蛋白的表达及其与甲胎蛋白增强剂中B元件的结合活性。人 HNF-1α 和 HNF-1β 的多克隆抗体是由谷胱甘肽 S-转移酶融合蛋白产生的。从测试的组织中制备核提取物。通过蛋白质印迹法测量分离的细胞核中 HNF-1α 和 HNF-1β 蛋白的表达,并通过凝胶迁移率测定检测它们的结合活性。免疫组织化学在冷冻和石蜡包埋切片中进行。 Western印迹表明,HNF-1α蛋白在高分化HCC组织中过表达,但与周围非HCC组织相比,从高分化到低分化HCC下降。尽管HNF-1β在癌组织中比周围的非癌部分更丰富,但从高分化HCC到低分化HCC,HNF-1β的表达并不明显。凝胶迁移率测定中,HNF-1α结合活性测定呈下降趋势。这些发现提供了HNF-1α改变对HCC分化影响的证据,即当HNF-1α表达减少且HNF-1β竞争结合先前被HNF-1α占据的元件时,HCC的组织学分化变差(Wang W等人,J Pathol 正在出版)。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ohta K: "Telomerase Activity in Hepatocellular Carcinoma with the use of Modified TRAP Assay" J Gastroenterol in press.
Ohta K:“使用改良 TRAP 测定法检测肝细胞癌中的端粒酶活性”J Gastroenterol 正在出版。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hayashi Y: "Thymoma, its tumorigenesis and progression in relationship with expression of EGF, EGF-Receptor, p53, v-erb and ras p21" Virchows Archiv. 426. 43-50 (1995)
Hayashi Y:“胸腺瘤,其肿瘤发生和进展与 EGF、EGF 受体、p53、v-erb 和 ras p21 表达的关系”Virchows Archive。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Seo Y: "Overexpression of SAP-1,a human transmembrane-type protein tyrosine phosphatase in colorectal cancers" Biochem Biophys Res Commun. 231. 705-711 (1997)
Seo Y:“SAP-1(一种人跨膜型蛋白酪氨酸磷酸酶在结直肠癌中的过度表达)”Biochem Biophys Res Commun。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kawasaki K: "Developmental expression of the tight junction protein Occludin in the gastrointestinal tract in the chick embryo" Histochem Cell Biol in press.
Kawasaki K:“鸡胚胃肠道中紧密连接蛋白 Occludin 的发育表达”《组织化学细胞生物学》已出版。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hayashi Y: "Clinicopathologic and molecular pathologic approaches to Lowe's syndrome" Pediatr Pathol. 15. 389-402 (1995)
Hayashi Y:“劳氏综合征的临床病理学和分子病理学方法”Pediatr Pathol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAYASHI Yoshitake其他文献
HAYASHI Yoshitake的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAYASHI Yoshitake', 18)}}的其他基金
Identification and characterization of the phenotype of hepatic stem cells in various liver diseases, its application to frontier medicine
各种肝脏疾病中肝干细胞表型的鉴定、表征及其在前沿医学中的应用
- 批准号:
14370068 - 财政年份:2002
- 资助金额:
$ 5.06万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
THE ROLE OF TRANSCRIPTIONAL REGULATION FACTORS ON ONTOGENY,DIFFERENTIATION AND ONCOGENESIS ; ITS APPLICATION FOR HISTOPATHOLOGIC DIAGNOSIS
转录调控因子对个体发育、分化和癌发生的作用;
- 批准号:
05807014 - 财政年份:1993
- 资助金额:
$ 5.06万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
转录因子GATAD1(含GATA锌指结构域蛋白1)与NAT10(N-乙酰转移酶10)协同作用启动表观遗传学调控在肝细胞癌中的功能和机制研究及临床应用的探索
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:
转录因子PLAGL2对肝细胞癌分化命运及免疫抑制微环境调控的分子机制研究
- 批准号:82073280
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
转录中介因子1γ(TIF1γ)对肝癌干细胞异质性的调控作用与机制研究
- 批准号:81874065
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
代谢重编程通过O-GlcNAc修饰调控转录因子Sp1/HSF1稳定性参与肝细胞癌发生发展的机制研究
- 批准号:81602093
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
热休克转录因子 1 作为癌靶蛋白在肝细胞癌中的分子调控机理
- 批准号:30971508
- 批准年份:2009
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Hormonal control of NASH development and progression
NASH 发生和进展的激素控制
- 批准号:
10454874 - 财政年份:2019
- 资助金额:
$ 5.06万 - 项目类别:
Hormonal control of NASH development and progression
NASH 发生和进展的激素控制
- 批准号:
10265382 - 财政年份:2019
- 资助金额:
$ 5.06万 - 项目类别:
Hormonal control of NASH development and progression
NASH 发生和进展的激素控制
- 批准号:
9906041 - 财政年份:2019
- 资助金额:
$ 5.06万 - 项目类别:
Tumor suppressor roles of E2F7 & E2F8 in hepatocellular carcinoma
E2F7 的肿瘤抑制作用
- 批准号:
9457804 - 财政年份:2017
- 资助金额:
$ 5.06万 - 项目类别:
Mechanisms of TWIST1-induced sorafenib resistance in liver CA
TWIST1诱导肝CA索拉非尼耐药的机制
- 批准号:
8785775 - 财政年份:2014
- 资助金额:
$ 5.06万 - 项目类别: